FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis

PURPOSE: To provide a quantitative clinical-regulatory insight into the status of FDA orphan drug designations for compounds intended to treat lysosomal storage disorders (LSDs). METHODS: Assessment of the drug pipeline through analysis of the FDA database for orphan drug designations with descripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbade, Sven F., Zielonka, Matthias, Mechler, Konstantin, Kölker, Stefan, Hoffmann, Georg F., Staufner, Christian, Mengel, Eugen, Ries, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141691/
https://www.ncbi.nlm.nih.gov/pubmed/32267884
http://dx.doi.org/10.1371/journal.pone.0230898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141691/
https://www.ncbi.nlm.nih.gov/pubmed/32267884
http://dx.doi.org/10.1371/journal.pone.0230898

Ejemplares similares